简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:Here's how Allergan went from its start as a sleepy but beloved company out of Southern California in the 1950s to an acquisition target for AbbVie.
AbbVie is acquiring Botox-maker Allergan in a $63 billion deal, the companies said Tuesday.
Allergan has had a long history dating back to the 1940s. Over the years it's gone through major acquisitions, including some that have fallen through.
Visit Business Insider's homepage for more stories.
Allergan, the pharmaceutical company best known for making Botox, on Tuesday agreed to be acquired by AbbVie in a $63 billion deal.
Investors had been unhappy with Allergan's stock performance over the last year, and some have been vocal in calling for change.
Here's how the company went from its start as a small but beloved company out of Southern California in the 1950s to the latest takeover target.
This article was initially published in June 2018 and has been updated.
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.
Bill Gates warned Donald Trump before he took office of the dangers of a pandemic — and urged him to prioritize the US' preparedness efforts.
Of the 100 largest US metro areas, Zillow found that 26 saw a month-over-month decrease in median listing price, ranging from 0.1% to 3.3%.
Before the coronavirus, luxury conglomerate LVMH was posting record-breaking revenues and sending Bernard Arnault's net worth soaring.
Several officials agreed that the Fed's relief efforts — while necessary — pose economic risks if they go unchecked and aren't appropriately reversed.